Trial intelligence / Profile preview

Postoperative hypotension after remimazolam vs dexmedetomidine sedation in unilateral total hip arthroplasty under spinal anesthesia

KCT0008223Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam, dexmedetomidine in N/A, Hip arthritis, hip osteoarthritis, sponsored by Seoul National University Hospital. Started Feb 2023; status: completed.

02

Drugs

remimazolamdexmedetomidine
03

Conditions

N/AHip arthritiship osteoarthritis

Beyond the preview

Go deeper on KCT0008223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call